{"id":750182,"date":"2023-04-24T07:06:39","date_gmt":"2023-04-24T11:06:39","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/unicycive-announces-acceptance-of-multiple-datasets-to-be-presented-at-the-european-renal-association-congress\/"},"modified":"2023-04-24T07:06:39","modified_gmt":"2023-04-24T11:06:39","slug":"unicycive-announces-acceptance-of-multiple-datasets-to-be-presented-at-the-european-renal-association-congress","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/unicycive-announces-acceptance-of-multiple-datasets-to-be-presented-at-the-european-renal-association-congress\/","title":{"rendered":"Unicycive Announces Acceptance of Multiple Datasets to Be Presented at the European Renal Association Congress"},"content":{"rendered":"<h2>\nData highlights the potential safety and reno-protective effect of UNI-494<br \/>\n<\/h2>\n<div class=\"mw_release\">\n<p align=\"justify\">LOS ALTOS, Calif., April  24, 2023  (GLOBE NEWSWIRE) &#8212; Unicycive Therapeutics, Inc.\u00a0(Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for patients with unmet medical needs, today announced that two datasets highlighting the safety and suggestive efficacy of UNI-494 in animal models were accepted for oral presentation at the upcoming 60<sup>th<\/sup> European Renal Association Congress (ERA 2023) taking place from June 15-18, 2023, in Milan, Italy.<\/p>\n<p align=\"justify\">The following data will be presented at ERA 2023:<\/p>\n<p align=\"justify\">\n        <strong>Title: <\/strong>UNI-494 Does Not Significantly Affect Rat Respiratory Function<br \/><strong>Format: <\/strong>Focused Oral Presentation<br \/><strong>Presenter: <\/strong>Shalabh Gupta, M.D., Chief Executive Officer of Unicycive<\/p>\n<p align=\"justify\">\n        <strong>Title: <\/strong>UNI-494 Lowers Urinary b2-microglobulin Levels in Rats<br \/><strong>Format: <\/strong>Moderated Oral Presentation <br \/><strong>Presenter: <\/strong>Shalabh Gupta, M.D., Chief Executive Officer of Unicycive<\/p>\n<p align=\"justify\">\u201cWe are looking forward to the presentation of this growing body of evidence supporting the safety and suggestive clinical utility of UNI-494 to be reno-protective. There remains a great unmet need in renal diseases, and we believe UNI-494, with its novel mechanism of action that restores mitochondrial function, may be a promising therapy for acute kidney injury, a condition for which there are currently no approved treatments,\u201d said Shalabh Gupta, M.D., Chief Executive Officer of Unicycive, Inc.<\/p>\n<p align=\"justify\">\n        <strong>About\u00a0Unicycive Therapeutics<\/strong>\n      <\/p>\n<p align=\"justify\">Unicycive is focused on two kidney diseases with large unmet medical needs. We are developing Renazorb, an investigational phosphate binding agent using proprietary nanoparticle technology for the treatment of patients with hyperphosphatemia. We plan to file a New Drug Application (NDA) for Renazorb with the U.S. Food and Drug Administration (FDA) mid-year. We are also developing UNI-494, a new chemical entity with a novel mechanism of action that restores mitochondrial function in acute and chronic diseases. Our initial target for UNI-494 is acute kidney injury (AKI), for which there are currently no FDA-approved medicines.<\/p>\n<p align=\"justify\">\n        <strong>Investor Contact:<\/strong><br \/>\n        <br \/>ir@unicycive.com<br \/>(650) 900-5470<\/p>\n<p align=\"justify\">Anne Marie Fields<br \/>Stern Investor Relations <br \/>annemarie.fields@sternir.com<br \/>212-362-1200<\/p>\n<p align=\"justify\">SOURCE: Unicycive Therapeutics, Inc.<\/p>\n<p \/>\n      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgyMzUyNSM1NTUxODY0IzIyMTA3NjM=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/YzA4MjZkNDQtYmYxNi00OWI0LWIyMzQtNzI5YzY5M2FjZDBhLTEyMjIzMTY=\/tiny\/Unicycive-Therapeutics-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Data highlights the potential safety and reno-protective effect of UNI-494 LOS ALTOS, Calif., April 24, 2023 (GLOBE NEWSWIRE) &#8212; Unicycive Therapeutics, Inc.\u00a0(Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for patients with unmet medical needs, today announced that two datasets highlighting the safety and suggestive efficacy of UNI-494 in animal models were accepted for oral presentation at the upcoming 60th European Renal Association Congress (ERA 2023) taking place from June 15-18, 2023, in Milan, Italy. The following data will be presented at ERA 2023: Title: UNI-494 Does Not Significantly Affect Rat Respiratory FunctionFormat: Focused Oral PresentationPresenter: Shalabh Gupta, M.D., Chief Executive Officer of Unicycive Title: UNI-494 Lowers Urinary b2-microglobulin Levels in RatsFormat: Moderated Oral Presentation Presenter: Shalabh Gupta, M.D., Chief &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/unicycive-announces-acceptance-of-multiple-datasets-to-be-presented-at-the-european-renal-association-congress\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Unicycive Announces Acceptance of Multiple Datasets to Be Presented at the European Renal Association Congress&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-750182","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Unicycive Announces Acceptance of Multiple Datasets to Be Presented at the European Renal Association Congress - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/unicycive-announces-acceptance-of-multiple-datasets-to-be-presented-at-the-european-renal-association-congress\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Unicycive Announces Acceptance of Multiple Datasets to Be Presented at the European Renal Association Congress - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Data highlights the potential safety and reno-protective effect of UNI-494 LOS ALTOS, Calif., April 24, 2023 (GLOBE NEWSWIRE) &#8212; Unicycive Therapeutics, Inc.\u00a0(Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for patients with unmet medical needs, today announced that two datasets highlighting the safety and suggestive efficacy of UNI-494 in animal models were accepted for oral presentation at the upcoming 60th European Renal Association Congress (ERA 2023) taking place from June 15-18, 2023, in Milan, Italy. The following data will be presented at ERA 2023: Title: UNI-494 Does Not Significantly Affect Rat Respiratory FunctionFormat: Focused Oral PresentationPresenter: Shalabh Gupta, M.D., Chief Executive Officer of Unicycive Title: UNI-494 Lowers Urinary b2-microglobulin Levels in RatsFormat: Moderated Oral Presentation Presenter: Shalabh Gupta, M.D., Chief &hellip; Continue reading &quot;Unicycive Announces Acceptance of Multiple Datasets to Be Presented at the European Renal Association Congress&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/unicycive-announces-acceptance-of-multiple-datasets-to-be-presented-at-the-european-renal-association-congress\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-04-24T11:06:39+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgyMzUyNSM1NTUxODY0IzIyMTA3NjM=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/unicycive-announces-acceptance-of-multiple-datasets-to-be-presented-at-the-european-renal-association-congress\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/unicycive-announces-acceptance-of-multiple-datasets-to-be-presented-at-the-european-renal-association-congress\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Unicycive Announces Acceptance of Multiple Datasets to Be Presented at the European Renal Association Congress\",\"datePublished\":\"2023-04-24T11:06:39+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/unicycive-announces-acceptance-of-multiple-datasets-to-be-presented-at-the-european-renal-association-congress\\\/\"},\"wordCount\":338,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/unicycive-announces-acceptance-of-multiple-datasets-to-be-presented-at-the-european-renal-association-congress\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgyMzUyNSM1NTUxODY0IzIyMTA3NjM=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/unicycive-announces-acceptance-of-multiple-datasets-to-be-presented-at-the-european-renal-association-congress\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/unicycive-announces-acceptance-of-multiple-datasets-to-be-presented-at-the-european-renal-association-congress\\\/\",\"name\":\"Unicycive Announces Acceptance of Multiple Datasets to Be Presented at the European Renal Association Congress - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/unicycive-announces-acceptance-of-multiple-datasets-to-be-presented-at-the-european-renal-association-congress\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/unicycive-announces-acceptance-of-multiple-datasets-to-be-presented-at-the-european-renal-association-congress\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgyMzUyNSM1NTUxODY0IzIyMTA3NjM=\",\"datePublished\":\"2023-04-24T11:06:39+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/unicycive-announces-acceptance-of-multiple-datasets-to-be-presented-at-the-european-renal-association-congress\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/unicycive-announces-acceptance-of-multiple-datasets-to-be-presented-at-the-european-renal-association-congress\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/unicycive-announces-acceptance-of-multiple-datasets-to-be-presented-at-the-european-renal-association-congress\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgyMzUyNSM1NTUxODY0IzIyMTA3NjM=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgyMzUyNSM1NTUxODY0IzIyMTA3NjM=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/unicycive-announces-acceptance-of-multiple-datasets-to-be-presented-at-the-european-renal-association-congress\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Unicycive Announces Acceptance of Multiple Datasets to Be Presented at the European Renal Association Congress\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Unicycive Announces Acceptance of Multiple Datasets to Be Presented at the European Renal Association Congress - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/unicycive-announces-acceptance-of-multiple-datasets-to-be-presented-at-the-european-renal-association-congress\/","og_locale":"en_US","og_type":"article","og_title":"Unicycive Announces Acceptance of Multiple Datasets to Be Presented at the European Renal Association Congress - Market Newsdesk","og_description":"Data highlights the potential safety and reno-protective effect of UNI-494 LOS ALTOS, Calif., April 24, 2023 (GLOBE NEWSWIRE) &#8212; Unicycive Therapeutics, Inc.\u00a0(Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for patients with unmet medical needs, today announced that two datasets highlighting the safety and suggestive efficacy of UNI-494 in animal models were accepted for oral presentation at the upcoming 60th European Renal Association Congress (ERA 2023) taking place from June 15-18, 2023, in Milan, Italy. The following data will be presented at ERA 2023: Title: UNI-494 Does Not Significantly Affect Rat Respiratory FunctionFormat: Focused Oral PresentationPresenter: Shalabh Gupta, M.D., Chief Executive Officer of Unicycive Title: UNI-494 Lowers Urinary b2-microglobulin Levels in RatsFormat: Moderated Oral Presentation Presenter: Shalabh Gupta, M.D., Chief &hellip; Continue reading \"Unicycive Announces Acceptance of Multiple Datasets to Be Presented at the European Renal Association Congress\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/unicycive-announces-acceptance-of-multiple-datasets-to-be-presented-at-the-european-renal-association-congress\/","og_site_name":"Market Newsdesk","article_published_time":"2023-04-24T11:06:39+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgyMzUyNSM1NTUxODY0IzIyMTA3NjM=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/unicycive-announces-acceptance-of-multiple-datasets-to-be-presented-at-the-european-renal-association-congress\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/unicycive-announces-acceptance-of-multiple-datasets-to-be-presented-at-the-european-renal-association-congress\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Unicycive Announces Acceptance of Multiple Datasets to Be Presented at the European Renal Association Congress","datePublished":"2023-04-24T11:06:39+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/unicycive-announces-acceptance-of-multiple-datasets-to-be-presented-at-the-european-renal-association-congress\/"},"wordCount":338,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/unicycive-announces-acceptance-of-multiple-datasets-to-be-presented-at-the-european-renal-association-congress\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgyMzUyNSM1NTUxODY0IzIyMTA3NjM=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/unicycive-announces-acceptance-of-multiple-datasets-to-be-presented-at-the-european-renal-association-congress\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/unicycive-announces-acceptance-of-multiple-datasets-to-be-presented-at-the-european-renal-association-congress\/","name":"Unicycive Announces Acceptance of Multiple Datasets to Be Presented at the European Renal Association Congress - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/unicycive-announces-acceptance-of-multiple-datasets-to-be-presented-at-the-european-renal-association-congress\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/unicycive-announces-acceptance-of-multiple-datasets-to-be-presented-at-the-european-renal-association-congress\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgyMzUyNSM1NTUxODY0IzIyMTA3NjM=","datePublished":"2023-04-24T11:06:39+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/unicycive-announces-acceptance-of-multiple-datasets-to-be-presented-at-the-european-renal-association-congress\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/unicycive-announces-acceptance-of-multiple-datasets-to-be-presented-at-the-european-renal-association-congress\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/unicycive-announces-acceptance-of-multiple-datasets-to-be-presented-at-the-european-renal-association-congress\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgyMzUyNSM1NTUxODY0IzIyMTA3NjM=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgyMzUyNSM1NTUxODY0IzIyMTA3NjM="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/unicycive-announces-acceptance-of-multiple-datasets-to-be-presented-at-the-european-renal-association-congress\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Unicycive Announces Acceptance of Multiple Datasets to Be Presented at the European Renal Association Congress"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/750182","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=750182"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/750182\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=750182"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=750182"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=750182"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}